Please provide your email address to receive an email when new articles are posted on . High-dose erythropoietin did not improve outcomes for infants with hypoxic ischemic encephalopathy. Controlled ...
NORFOLK, Va.--(BUSINESS WIRE)--ReAlta Life Sciences, Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company dedicated to saving lives by rebalancing the inflammatory response to ...
Mild, intermittent oxygen deprivation in preterm infants disrupts brain connectivity, alters neuron development, and may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results